Despite a recent market rebound fueled by hopes of US-China trade negotiations, concerns linger about rich valuations and slower growth in India. While domestic investors are driving the rally, global investors remain cautious due to uncertainties surrounding US tariffs and their potential impact on the global economy.
Dr Reddy’s, Sun Pharma and other pharma stocks fall up to 3% as Trump threatens 25% tariff on India
Indian pharma stocks fell up to 3% after U.S. President Trump announced a 25% tariff on Indian imports over its trade with Russia. Concerns rose